Clinical studies recruiting near Redwood City

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · Kaiser Permanente- Marshall Medical Offices · NRG Oncology · NCT05946213 Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · Stanford University · Gilead Sciences · NCT06051617 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Kaiser Permanente- Marshall Medical Offices · NRG Oncology · NCT05174169 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Kaiser Permanente- Marshall Medical Offices · Alliance for Clinical Trials in Oncology · NCT06632327 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · Kaiser Permanente- Marshall Medical Offices · NRG Oncology · NCT06748222 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Kaiser Permanente- Marshall Medical Offices · NRG Oncology · NCT04852887 mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg
Phase 3 · Kaiser Permanente- Marshall Medical Offices · Alliance for Clinical Trials in Oncology · NCT05677490 Inappropriate Sinus Tachycardia Registry
Phase N/A · Sequoia Hospital · AtriCure, Inc. · NCT05107635 S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · Kaiser Permanente-Redwood City · SWOG Cancer Research Network · NCT03418961 Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
Phase 3 · Stanford Medicine - Clinical and Translational Research Unit · Bausch Health Americas, Inc. · NCT07428538 Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
Phase N/A · Kaiser Permanente Redwood City Medical Center · University of Cincinnati · NCT05338697 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · Kaiser Permanente- Marshall Medical Offices · National Cancer Institute (NCI) · NCT04267848 Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Phase 2/Phase 3 · Kaiser Permanente-Redwood City · SWOG Cancer Research Network · NCT03851445 A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupil
Phase 3 · Stanford University School of Medicine - Redwood City /ID# 2 · AbbVie · NCT06389136 A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NA · Kaiser Permanente- Marshall Medical Offices · NRG Oncology · NCT04251052 Assessment of CCM in HF With Higher Ejection Fraction
NA · Sequoia Hospital · Impulse Dynamics · NCT05064709 Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Phase 3 · Kaiser Permanente- Marshall Medical Offices · NRG Oncology · NCT06580314 MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Redwood City Medical Center - Kaiser Permanente · Stryker Instruments · NCT03072927 A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Sever
Phase 3 · Stanford University School of Medicine - Redwood City /ID# 2 · AbbVie · NCT06012240 ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Phase N/A · Redwood City · Guardant Health, Inc. · NCT05059444 Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Phase N/A · Kaiser Permanente- Marshall Medical Offices · SWOG Cancer Research Network · NCT04871542 Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Phase 3 · Kaiser Permanente-Redwood City · SWOG Cancer Research Network · NCT03678025 Evaluating Cryopreserved Osteochondral Allograft Cores for the Treatment of Osteochondral Lesions in the Knee
NA · Stanford Medicine-Orthopaedics and Sports Medicine in Redwoo · AlloSource · NCT06216756 Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Phase 2 · Kaiser Permanente-Redwood City · Alliance for Clinical Trials in Oncology · NCT02523014 Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Phase N/A · Kaiser Permanente- Marshall Medical Offices · Wake Forest University Health Sciences · NCT06418204 Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal
Phase 3 · Kaiser Permanente- Marshall Medical Offices · NRG Oncology · NCT05879926 Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Phase 3 · Kaiser Permanente Redwood City Medical Center, Redwood City, · Yale University · NCT03907046 A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderate
Phase 3 · Stanford Medicine Outpatient Center · Hoffmann-La Roche · NCT06819891 A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants
Phase 3 · Stanford Medicine Outpatient Center · Hoffmann-La Roche · NCT06588855 Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leu
Phase 3 · Kaiser Permanente- Marshall Medical Offices · Alliance for Clinical Trials in Oncology · NCT03150693

Look up another city

Look up another condition